Lipoic Acid for Progressive Multiple Sclerosis (MS)
common.study.values.description
“Lipoic Acid for Progressive Multiple Sclerosis (MS)”
The purpose of the study is to determine if lipoic acid can preserve mobility and protect the brain in progressive forms of multiple sclerosis.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-yes
Drug - Lipoic acid
1200 mg taken by mouth daily for two years starting on day one of the study and ending on the last day of study participation.
Drug - Placebo
The placebo comparator will be taken by mouth daily for two years starting on day one of the study and ending on the last day of study participation
participant.views.study.view.additional
participant.views.study.view.scientific-title
Lipoic Acid for the Treatment of Progressive Multiple Sclerosis
common.study.values.clinical-trial-id
NCT03161028
participant.views.study.view.id
YerGEa
